Evidence map›Paper›PMID 15731095›Full record

ArticleInfection and immunity2005

Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection.

Malcolm S Duthie, Maria Kahn, Maria White, Raj P Kapur, Stuart J Kahn

Abstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. CD1d- and MR1-Restricted T Cells in Sepsis.Frontiers in immunology · 2015
    Review
  6. Selection of self-reactive T cells in the thymus.Annual review of immunology · 2012
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Malcolm S DuthieInfectious Disease Research Institute, 1124 Columbia St., Suite 600, Seattle, WA 98104, USA.
Maria Kahn
Maria White
Raj P Kapur
Stuart J Kahn

Funding

The Function of NKT Cells During T Cruzi InfectionR01AI049455 · NIAID · UNIVERSITY OF WASHINGTON · PI KAHN, STUART J · 2001 to 2004
$1.5M
NIAID NIH HHS R01 AI049455
6 · The paper itself

Abstract

Mechanisms of natural killer T (NKT)-cell activation remain unclear. Here, we report that during Trypanosoma cruzi infection, interleukin-12 (IL-12) deficiency or anti-CD1d antibody treatment prevents normal activation. The required IL-12 arises independently of MyD88. The data support a model of normal NKT-cell activation that requires IL-12 and TCR stimulation.

Indexed as

AnimalsAntigen PresentationAntigens, CD1Antigens, CD1dChagas DiseaseInterleukin-12Killer Cells, NaturalLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C57BLTrypanosoma cruziAntigens, CD1Antigens, CD1dInterleukin-12

Identifiers

PMID15731095
PMCPMC1064964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.